Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk

Journal of the National Cancer Institute

Volumn 99, Issue 5, 2007, Pages 386-395

  Kerlikowske, Karla ^a,b,c   Ichikawa, Laura ^d   Miglioretti, Diana L ^d,e   Buist, Diana S M ^d   Vacek, Pamela M ^f   Smith Bindman, Rebecca ^b   Yankaskas, Bonnie ^g   Carney, Patricia A ^h   Ballard Barbash, Rachel ⁱ  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INVASION; CANCER RISK; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PAGET NIPPLE DISEASE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; BREAST; BREAST TUMOR; CANCER REGISTRY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; PREDICTION AND FORECASTING; PREMENOPAUSE; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS;

EID: 33947723142     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk066     Document Type: Article

References (51)

1. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
2. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
3. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
4. Saftlas AF, Wolfe JN, Hoover RN, Brinton LA, Schairer C, Salane M, et al. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 1989;129:518-26.
5. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control Study. AJR Am J Roentgenol 1987;148:1087-92.
6. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH, et al. Family history, age, and risk of breast cancer. JAMA 1993;270:338-43.
7. Prevrhal S, Shepherd JA, Smith-Bindman R, Cummings SR, Kerlikowske K. Accuracy of mammographic breast density analysis: Formal training of operators with varying background. Cancer Epidemiol Biomarkers Prev 2002;11:1389-93.
8. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 2005;94:115-22.
9. Vacek PM, Geller B. A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 2004;13:715-22.
10. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2090-5.
11. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003;95:556-8.
12. American College of Radiology. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS®). 3rd ed. Reston (VA): American College of Radiology; 2003.
13. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography? JAMA 1996;276:33-8.
14. Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med 1999;130:262-9.
15. Kerlikowske K, Miglioretti DL, Barbash R, Weaver D, Buist DSM, Barlow W, et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 2003;21:4314-21.
16. Boyd NF, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53.
17. White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40 to 49 years. J Natl Cancer Inst 1998;90:906-10.
18. Vachon CM, Kuni CC, Anderson K, Anderson E, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000;11:653-62.
19. Salminen TM, Hakama M, Heikkila MM, Saarenmaa IE. Favorable change in mammographic parenchmal patterns and breast cancer risk factors. Int J Cancer 1998;78:410-4.
20. Warwick J, Pinney E, Warren RML, Duffy SW, Howell A, Wilson M, et al. Breast density and breast cancer risk factors in a high-risk population. Breast 2003;12:10-6.
21. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic density by age (United States). Cancer Causes Control 2000;11:955-63.
22. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001;285: 171-6.
23. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike C, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7.
24. Atkinson C, Warren R, Bingham SA, Day NE. Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999;8:863-6.
25. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J. Effect of tamoxifen on mamographic density. Cancer Epidemiol Biomarkers Prev 2000;9:917-21.
26. Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW. Effect of Tamoxifen on breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004;96:621-8.
27. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 1998;90:1371-88.
28. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, et al. Overview of the main outcomes in breast cancer prevention trials. Lancet 2003;361:296-300.
29. van Gils CH, Hendriks JHCL, Holland R, Karssemeijer N, Otten JDM, Straatman H, et al. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 1999;8: 509-15.
30. Maskarinee G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006;15:732-9.
31. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast Cancer Surveillance Consortium: A national mammography screening and outcomes database. AJR Am J Roentgenol 1997;169:1001-8.
32. Lane P, Nelder J. Analysis of covariance and standardization as instances of prediction. Biometrics 1982;38:613-21.
33. Graubard B, Korn E. Predictive margins with survey data. Biometrics 1999;55:652-9.
34. Reade-Christopher SJ, Kupper LL. Effects of exposure misclassification on regression analyses of epidemiologic follow-up study data. Biometrics 1991;47:535-48.
35. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
36. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, et al. Heritability of mammograpbic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
37. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, et al. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:343-9.
38. Warner E, Lockwood GA, Tritchler DL, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: A meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 1992;16:67-72.
39. Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, et al. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 1999;8:873-9.
40. Boyd NF, Jensen HM, Cooke G, Lee Han H, Lockwood GA, Miller AB. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Eur J Cancer Prev 2000;9:15-24.
41. Hartmann L, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.
42. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000;60:3744-8.
43. Byrne C, Hankinson SE, Colditz GA, Willett W, Speizer FE. Plasma prolactin and mammographic breast density in postmenopausal women. Proc Am Assoc Cancer Res 2001;42:153.
44. Kerlikowske K, Grady D, Barclay J, Frankel S, Ominsky S, Sickles EA, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). J Natl Cancer Inst 1998;90:1801-9.
45. Ciatto S, Houssami N, Apruzzese A, Bassetti E, Brancato B, Carozzi F, et al. Categorizing breast mammographic density: Intra- and interobserver reproducibility of BI-RADS density categories. Breast 2005;14:269-75.
46. Gustafson P. Measurement error and misclassification in statistics and epidemiology: Impacts and Bayesian adjustments. CRC Press; Boca Raton (FL): 2004.
47. McCormack VA, dos Santos Silva I. Breast density and parenchymal Patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
48. Boyd NF, Martin LJ, Sun L, Gun H, Chiarelli A, Hislop G, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:2086-92.
49. Barlow W, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff LT, Carney PA, et al. A prospective breast cancer risk prediction model among women undergoing screening mammography. J Natl Cancer Inst 2006; 98:1204-14.
50. Kaplan C, Haas JS, Perez-Stable EJ, Somkin C, Gregorich S, Des Jarlais G, et al. Breast cancer risk reduction options: Awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev 2006;15:162-6.
51. Armstrong K, Quistberg A, Micco E, Domchek S, Guerra C. Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med 2006;166:2260-5.